Uterine Leiomyosarcoma in a Young Woman: A Report of a Rare Case

被引:0
作者
Heda, Sakshi [1 ]
Gattani, Preeti [2 ]
Heda, Ayush [1 ]
Zade, Rasika D. [2 ]
Gattani, Rajesh G. [3 ]
机构
[1] All India Inst Med Sci, Obstet & Gynaecol, Rishikesh, India
[2] Deemed be Univ, Datta Meghe Inst Higher Educ & Res, Datta Meghe Med Coll, Obstet & Gynaecol, Nagpur, India
[3] Deemed be Univ, Datta Meghe Inst Higher Educ & Res, Jawaharlal Nehru Med Coll, Gen Surg, Wardha, India
关键词
leiomyoma; myomectomy; nulliparous; infertility; uterine sarcomas; leiomyosarcoma; SARCOMA; GYNECOLOGY; FEDERATION; OBSTETRICS;
D O I
10.7759/cureus.63116
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Uterine leiomyosarcoma (LMS) is an uncommon disease that arises from the smooth muscles present in the uterus. It usually occurs in post-menopausal women. Due to its aggressive nature, it has a very poor prognosis. We present a case of uterine LMS, which presented at a young age of 35 years for infertility, which is rare at this age. She had a fundal fibroid for which myomectomy was done. On histopathology, she was diagnosed with LMS. It is very difficult and nearly impossible to diagnose LMS preoperatively by available imaging modalities. There is an urgent need for a reliable preoperative risk scoring system that can help in diagnosing malignancy so that a correct surgical pathway and treatment can be offered to patients. A total abdominal hysterectomy (TAH) with bilateral salpingo-oophorectomy (BSO) was done and was advised adjuvant chemotherapy. The patient remained disease-free and was put on chemotherapy.
引用
收藏
页数:9
相关论文
共 13 条
[1]   Age-Stratified Risk of Unexpected Uterine Sarcoma Following Surgery for Presumed Benign Leiomyoma [J].
Brohl, Andrew S. ;
Li, Li ;
Andikyan, Vaagn ;
Obican, Sarah G. ;
Cioffi, Angela ;
Hao, Ke ;
Dudley, Joel T. ;
Ascher-Walsh, Charles ;
Kasarskis, Andrew ;
Maki, Robert G. .
ONCOLOGIST, 2015, 20 (04) :433-439
[2]  
Buzinskiene Diana, 2018, Acta Med Litu, V25, P206, DOI [10.6001/actamedica.v25i4.3931, 10.6001/actamedica.v25i4.3931]
[3]  
Byar Katherine L, 2022, J Adv Pract Oncol, V13, P70, DOI [10.6004/jadpro.2022.13.1.6, 10.6004/jadpro.2022.13.1.6]
[4]   Uterine leiomyosarcoma: a rare clinical entity [J].
Dunphy, Louise ;
Sheridan, Gemma .
BMJ CASE REPORTS, 2021, 14 (08)
[5]   The management of patients with uterine sarcoma: A debated clinical challenge [J].
Gadducci, Angiolo ;
Cosio, Stefania ;
Romanini, Antonella ;
Genazzani, Andrea Riccardo .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2008, 65 (02) :129-142
[6]   Uterine Leiomyosarcoma [J].
Juhasz-Boess, Ingolf ;
Gabriel, Lena ;
Bohle, Rainer M. ;
Horn, Lars C. ;
Solomayer, Erich-Franz ;
Breitbach, Georg-Peter .
ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 (11) :680-686
[7]  
Kaur Khushpreet, 2014, J Midlife Health, V5, P202, DOI 10.4103/0976-7800.145175
[8]   Incidence of uterine leiomyosarcoma and endometrial stromal sarcoma in Nordic countries: Results from NORDCAN and NOCCA databases [J].
Koivisto-Korander, R. ;
Martinsen, J. I. ;
Weiderpass, E. ;
Leminen, A. ;
Pukkala, E. .
MATURITAS, 2012, 72 (01) :56-60
[9]   Uterine leiomyosarcoma: Epidemiology, contemporary treatment strategies and the impact of uterine morcellation [J].
Ricci, Stephanie ;
Stone, Rebecca L. ;
Fader, Amanda N. .
GYNECOLOGIC ONCOLOGY, 2017, 145 (01) :208-216
[10]   Uterine leiomyosarcoma: A review of the literature and update on management options [J].
Roberts, Maureen E. ;
Aynardi, Jason T. ;
Chu, Christina S. .
GYNECOLOGIC ONCOLOGY, 2018, 151 (03) :562-572